A potent cyclic peptide targeting SPSB2 protein as a potential anti-infective agent

Journal of Medicinal Chemistry

Volumn 57, Issue 16, 2014, Pages 7006-7015

  Yap, Beow Keat ^a   Leung, Eleanor W W ^a   Yagi, Hiromasa ^a   Galea, Charles A ^a   Chhabra, Sandeep ^a   Chalmers, David K ^a   Nicholson, Sandra E ^b,c   Thompson, Philip E ^a   Norton, Raymond S ^a  

^a MONASH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOPEPTIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL; BINDING SITE; BLOOD; CHEMISTRY; DRUG EFFECTS; HUMAN; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN TRANSPORT; SURFACE PLASMON RESONANCE;

ANIMALS; ANTI-INFECTIVE AGENTS; BINDING SITES; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR TARGETED THERAPY; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN TRANSPORT; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; SURFACE PLASMON RESONANCE;

EID: 84906861624     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm500596j     Document Type: Article

References (37)

1. Chakravortty, D.; Hensel, M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens Microbes Infect. 2003, 5, 621-627
2. Khan, S. A.; Strijbos, P. J.; Everest, P.; Moss, D.; Stratford, R.; Mastroeni, P.; Allen, J.; Servos, S.; Charles, I. G.; Dougan, G.; Maskell, D. J. Early responses to Salmonella typhimurium infection in mice occur at focal lesions in infected organs Microb. Pathog. 2001, 30, 29-38
3. Chan, E. D.; Chan, J.; Schluger, N. W. What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge Am. J. Respir. Cell Mol. Biol. 2001, 25, 606-612
4. Stenger, S.; Donhauser, N.; Thüring, H.; Röllinghoff, M.; Bogdan, C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase J. Exp. Med. 1996, 183, 1501-1514
5. Scharton-Kersten, T. M.; Yap, G.; Magram, J.; Sher, A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii J. Exp. Med. 1997, 185, 1261-1274
6. Kuang, Z.; Lewis, R. S.; Curtis, J. M.; Zhan, Y.; Saunders, B. M.; Babon, J. J.; Kolesnik, T. B.; Low, A.; Masters, S. L.; Willson, T. A.; Kedzierski, L.; Yao, S.; Handman, E.; Norton, R. S.; Nicholson, S. E. The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation J. Cell Biol. 2010, 190, 129-141
7. Filippakopoulos, P.; Low, A.; Sharpe, T. D.; Uppenberg, J.; Yao, S.; Kuang, Z.; Savitsky, P.; Lewis, R. S.; Nicholson, S. E.; Norton, R. S.; Bullock, A. N. Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4 J. Mol. Biol. 2010, 401, 389-402
8. Lewis, R. S.; Kolesnik, T. B.; Kuang, Z.; D'Cruz, A. A.; Blewitt, M. E.; Masters, S. L.; Low, A.; Willson, T.; Norton, R. S.; Nicholson, S. E. TLR regulation of SPSB1 controls inducible nitric oxide synthase induction J. Immunol. 2011, 187, 3798-3805
9. Nishiya, T.; Matsumoto, K.; Maekawa, S.; Kajita, E.; Horinouchi, T.; Fujimuro, M.; Ogasawara, K.; Uehara, T.; Miwa, S. Regulation of inducible nitric-oxide synthase by the SPRY domain- and SOCS box-containing proteins J. Biol. Chem. 2011, 286, 9009-9019
10. Matsumoto, K.; Nishiya, T.; Maekawa, S.; Horinouchi, T.; Ogasawara, K.; Uehara, T.; Miwa, S. The ECS(SPSB) E3 ubiquitin ligase is the master regulator of the lifetime of inducible nitric-oxide synthase Biochem. Biophys. Res. Commun. 2011, 409, 46-51
11. Camerino, M. A.; Chalmers, D. K.; Thompson, P. E. Computer-assisted design of cyclic peptides and peptidomimetics Chim. Oggi 2008, 26, 46-51
12. Fletcher, J. M.; Hughes, R. A. Modified low molecular weight cyclic peptides as mimetics of BDNF with improved potency, proteolytic stability and transmembrane passage in vitro Bioorg. Med. Chem. 2009, 17, 2695-2702
13. Hess, S.; Linde, Y.; Ovadia, O.; Safrai, E.; Shalev, D. E.; Swed, A.; Halbfinger, E.; Lapidot, T.; Winkler, I.; Gabinet, Y.; Faier, A.; Yarden, D.; Xiang, Z.; Portillo, F. P.; Haskell-Luevano, C.; Gilon, C.; Hoffman, A. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity J. Med. Chem. 2008, 51, 1026-1034
14. Byk, G.; Halle, D.; Zeltser, I.; Bitan, G.; Selinger, Z.; Gilon, C. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P J. Med. Chem. 1996, 39, 3174-3178
15. Hayouka, Z.; Hurevich, M.; Levin, A.; Benyamini, H.; Iosub, A.; Maes, M.; Shalev, D. E.; Loyter, A.; Gilon, C.; Friedler, A. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein Bioorg. Med. Chem. 2010, 18, 8388-8395
16. Piserchio, A.; Salinas, G. D.; Li, T.; Marshall, J.; Spaller, M. R.; Mierke, D. F. Targeting specific PDZ domains of PSD-95: structural basis for enhanced affinity and enzymatic stability of a cyclic peptide Chem. Biol. 2004, 11, 469-473
17. Richardson, J. S. The anatomy and taxonomy of protein structure Adv. Protein Chem. 1981, 34, 167-339
18. 19F NMR as a probe of ligand interaction with the iNOS binding site of SPRY-domain containing SOCS box protein 2 Chem. Biol. Drug Des. 2014, 10.1111/cbdd.12355
19. Kuang, Z.; Yao, S.; Xu, Y.; Lewis, R. S.; Low, A.; Masters, S. L.; Willson, T. A.; Kolesnik, T. B.; Nicholson, S. E.; Garrett, T. J. P.; Norton, R. S. SPRY domain-containing SOCS box protein 2: crystal structure and residues critical for protein binding J. Mol. Biol. 2009, 386, 662-674
20. Bodenhausen, G.; Ruben, D. J. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy Chem. Phys. Lett. 1980, 69, 185-189
21. Wouters, M. A.; Fan, S. W.; Haworth, N. L. Disulfides as redox switches: from molecular mechanisms to functional significance Antioxid. Redox Signaling 2010, 12, 53-91
22. Schafer, F. Q.; Buettner, G. R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radical Biol. Med. 2001, 30, 1191-1212
23. Cumming, R. C.; Andon, N. L.; Haynes, P. A.; Park, M.; Fischer, W. H.; Schubert, D. Protein disulfide bond formation in the cytoplasm during oxidative stress J. Biol. Chem. 2004, 279, 21749-21758
24. Hampton, M. B.; Kettle, A. J.; Winterbourn, C. C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing Blood 1998, 92, 3007-3017
25. Ramachandran, G. N.; Ramakrishnan, C.; Sasisekharan, V. Stereochemistry of polypeptide chain configurations J. Mol. Biol. 1963, 7, 95-99
26. α- fluorenylmethoxycarbonylamino acids on polyamide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide J. Chem. Soc., Perkin. Trans. 1 1981, 538-546
27. 15N assignments of the 25 kDa SPRY domain-containing SOCS box protein 2 (SSB-2) J. Biomol. NMR 2005, 31, 69-70
28. 15N chemical shift referencing in biomolecular NMR J. Biomol. NMR 1995, 6, 135-140
29. Shaka, A. J.; Lee, C. J.; Pines, A. Iterative schemes for bilinear operators; application to spin decoupling J. Magn. Reson. (1969) 1988, 77, 274-293
30. Hwang, T. L.; Shaka, A. J. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients J. Magn. Reson. A 1995, 112, 275-279
31. Güntert, P. Automated NMR structure calculation with CYANA Methods Mol. Biol. 2004, 278, 353-378
32. Shen, Y.; Bax, A. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks J. Biomol. NMR 2013, 56, 227-241
33. Wagner, G.; Braun, W.; Havel, T. F.; Schaumann, T.; Go, N.; Wüthrich, K. Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic pancreatic trypsin inhibitor determined using two different algorithms, DISGEO and DISMAN J. Mol. Biol. 1987, 196, 611-639
34. 1H chemical shifts in proteins J. Biomol. NMR 1997, 9, 359-369
35. Koradi, R.; Billeter, M.; Wüthrich, K. MOLMOL: a program for display and analysis of macromolecular structures J. Mol. Graph. 1996, 14 (51-55) 29-32
36. Wormald, S.; Zhang, J. G.; Krebs, D. L.; Mielke, L. A.; Silver, J.; Alexander, W. S.; Speed, T. P.; Nicola, N. A.; Hilton, D. J. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling J. Biol. Chem. 2006, 281, 11135-11143
37. Nicholson, S. E.; Novak, U.; Ziegler, S. F.; Layton, J. E. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK Blood 1995, 86, 3698-3704